Rifampin Augmentation in Hardware Infections: A Case Report of Thrombocytopenia

Abstract

Get full access to this article

View all access options for this article.

References

Osmon

Berbari

Berendt

, et al; Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1-e25. doi:10.1093/cid/cis803

Forrest

Tamura

Rifampin combination therapy for nonmycobacterial infections. Clin Microbiol Rev. 2010;23:14-34. doi:10.1128/CMR.00034-09

Poole

Stradling

Worlledge

Potentially serious side effects of high-dose twice-weekly rifampicin. Br Med J. 1971;3:343-347.

A controlled trial of daily and intermittent rifampicin and ethambutol in retreatment of patients with pulmonary tuberculosis: results up to 30 months. Tubercle. 1975;56:179-189.

Blajchman

Lowry

Pettit

Stradling

Rifampicin-induced immune thrombocytopenia. Br Med J. 1970;3:24-26.

Leggat

PO.

Rifampicin and thrombocytopenia. Lancet. 1971;2:103-104.

Mori

Izawa

Fujikawa

, et al. A case of acute and severe thrombocytopenia due to readministration of rifampicin. J Infect Chemother. 2011;17:288-290. doi:10.1007/s10156-010-0117-x

Naranjo

Busto

Sellers

, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.